US2884427A - Synthesis of coumestrol and its esters - Google Patents

Synthesis of coumestrol and its esters Download PDF

Info

Publication number
US2884427A
US2884427A US710586A US71058658A US2884427A US 2884427 A US2884427 A US 2884427A US 710586 A US710586 A US 710586A US 71058658 A US71058658 A US 71058658A US 2884427 A US2884427 A US 2884427A
Authority
US
United States
Prior art keywords
coumestrol
esters
reaction
estrogenic
coumarin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US710586A
Inventor
Oliver H Emerson
Emanuel M Bickoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US710586A priority Critical patent/US2884427A/en
Application granted granted Critical
Publication of US2884427A publication Critical patent/US2884427A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A23K20/126Lactones

Definitions

  • This invention relates in general to coumarin derivatives and processes for synthesizing them.
  • the objects of the invention include the provision of novel methods for synthesizing coumestrol and its esters and the provision of new cournarin derivatives valuable as intermediates in the preparation of coumestrol and the esters thereof. Further objects and advantages of the invention will be evident from the following description.
  • coumestrol EXAMPLE I a Preparation of 3(2,4-dimethoxyphenyl)-4,7- dihydroxy coumarin Omega (2,4-dimethoxyphenyl) resacetophenone (3.1 g.), acetone (50 ml.), methyl chloroformate (2 ml.), and potassium carbonate (8 g.) were refluxed for four hours. The reaction mixture was cooled, diluted with 100 ml. of water and acidified with hydrochloric acid. The precipitate was filtered, washed with Water and dried. The dry precipitate was dissolved in about 20 ml.
  • the coumetrol diacetate was filtered off and recrystallized from acetic acid.
  • the recrystallized product had a melting point of 234-23S C.
  • product may also be termed 7',6-diacetyloxy coumarino. (3,4'-3,2) -coumarone. It has the formula- OHIg 0-
  • the yield was 50%, based on the amount of The It will be found in a practice of the method exemplified above that many variations may be followed within the scope of the invention.
  • a preferred starting material is omega (2,4-dimethoxyphenyl) resacetophenone.
  • the substituents at the 2 and 4 positions he methoxy groups; other alkoxy substituents may be present at these positions,
  • the starting material may be an omega (2,4-dialkoxyphenyl) resacetophenone.
  • the 'alkoxy groups are of short carbon chain length such as methoxy, ethoxy, propoxy, isopropoxy, or butoxy. Such alkoxy groups are easily converted into hydroxy groups as. required in a further step of the synthesis.
  • omega (2,4-dialkoxyphenyl) resacetophenones may be prepared as well known in the art by condensation of resorcinol with a 2,4-dialkoxyphenyl acetonitrile in the presence of HCl and zinc chloride.
  • this compound is reacted with at least two moles, but preferably an excess, of an alkyl haloformate.
  • Methyl chloroformate is generally preferred as the latter reactant but analogous esters such as the ethyl, propyl, isopropyl, or butyl esters of chloroformic, bromoformic, or iodoforrnic acid may be employed.
  • the reaction is conducted under essentially anhydrous conditions.
  • the temperature of reaction is not critical and may vary, for example, from O to 100 C. Usually a temperature of about 50-70 C.
  • ,An inert solvent is preferably added to the reactants to promote contact therebetween.
  • Suitable solvents are for example, benzene, toluene, xylene, dioxane, acetone, ether, methyl-ethyl ketone, diethyl ketone, diisopropyl ether, the dimethyl or diethyl ethers of ethylene glycol, etc.
  • refluxing the reactants in acetone (boiling point 56 C.) is preferred.
  • an esterification promoter having moderate alkalinity is preferably employed.
  • an alkali metal carbonate or bicarbonate or a tertiary amine such as pyridine, quinoline, N-dimethyl aniline, N-dimethyl' cyclohexylamine, N-methyl piperidine, etc.
  • the alkaline agent is added in at least the stoichiometrical amount required to neutralize the hydrogen halide evolv d in the reaction.
  • the substituted resacetophenone and haloformate react to form an intermediate which may be described as a 2-hydroxy-4-alkylcarbonatophenyl-m-carbomethoxy-2,4-dimethoxybenzyl ketone.
  • the intermediate is contacted with an alkaline agent such as potassium hydroxide, sodium hydroxide, an alkali metal alcoholate, or the like.
  • an alkaline agent such as potassium hydroxide, sodium hydroxide, an alkali metal alcoholate, or the like.
  • the reaction may be conducted in an aqueous system but preferably the reactants are dissolved in an inert organic solvent such as methanol, ethanol, propanol, isopropanol, any of the isomeric butyl alcohols, the mono-methyl or mono-ethyl ethersof ethylene glycol, etc.
  • the amount This step facilitates isolation-of the.
  • the 3(2,4-dialkoxyphenyl)-4,7-dihydroxy coumarin is dealkylated and cyclized to form coumestroL
  • the substituted coumarin is heated with a salt of an aromatic amine and a hydrohalic acid.
  • Suitable salts are, for example, the hydrochlorides or hydrobromides of aniline, alpha-naphthyl amine, betanaphthyl amine, o-toluidine, m-toluidine, p-toluidine,
  • the amine salt is provided in an amount to furnish 2 mols thereof per mol of substituted coumarin.
  • an excess of amine salt is employed to operate both as reactant and as a flux to lower the melting point of the reaction mixture.
  • the reaction essentially involves mixing the substituted coumarin and amine salt and heating at a temperature at which the mixture becomes liquid. This temperature will usually be about ZOO-300 C. depending on the amine salt used and the proportion thereof in the mix-
  • the reaction is preferably conducted under an atmosphere of an inert gas, such as carbon dioxide or nitrogen, to minimize oxidative side-reactions. Com pletion of the reaction is indicated by the crystallization of coumestrol from the molten mass whereby the mass eventually becomes essentially solid.
  • Coumestrol may be recovered from the reaction mixture by first extracting the amine salt therefrom with water and re-crystal lizing the residual coumestrol from methanol or methamol-chloroform. Coumestrol may also be isolated by distillation since it sublimes at 325 C. under atmospheric pressure or at 175 C. under vacuum (7 microns pressure).
  • the coumestrol prepared by the cyclization and dealkylation described above is reacted with an acylating agent, for example, the anhydride, chloride, bromide or iodide of an acid such as acetic, propionic, lbutyric, isobutyric, valeric, caproic, caprylic, capric, lauric, palmitic, stearic, oleic, palmitoleic, arachidic, etc.
  • an acylating agent for example, the anhydride, chloride, bromide or iodide of an acid such as acetic, propionic, lbutyric, isobutyric, valeric, caproic, caprylic, capric, lauric, palmitic, stearic, oleic, palmitoleic, arachidic, etc.
  • the acylating agent is employed in a proportion to furnish at least 'moles of the acylating agent per mole of coumestrol thus to ensure esten'fying both hydroxyl groups.
  • an inert solvent may be added, or, in the alternative, such as excess of acylating agentmay be used as to function as both reactant and solvent.
  • Suitable inert solvents are for example benzene, toluene, xylene, dioxane, acetone, ether, methyl-ethyl ketone, diethyl ketone, diisopropyl ether, the diethyl ether of ethylene glycol, etc.
  • the temperature of reaction is not critical andmayvbe-variedfrom about 0 to .150 C.
  • a conventional esterificationpromoter is added, for example, the alkali metal salt of the acid in question (e.g., sodium acetate where coumestrol acetate is being prepared), pyridine, quinoline, potassium carbonate,” and the like.
  • the coumestrol esters are readily isolatable from the reaction mixture on addition of water since they are relatively insoluble in this solvent.
  • the intermediate compounds which may be produced in accordance with the procedure illustrated in Example I, part a, are new compounds not heretofore prepared or described.
  • These 3(2,4-dialkoxyphenyl)-4,7-dihydroxy coumarins may be depicted by the formulao-Qoa C// (in R wherein the ORs represent the same, or dissimilar, alkoxy radicals particularly lower alkoxy radicals such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, etc.
  • These compounds are particularly useful as intermediates in the preparation of coumestrol and coumestrol esters as described herein.
  • the coumestrol as produced in accordance with the invention is identical with coumestrol as isolated from plant materials and can be employed in the same manner as native coumestrol for its estrogenic activity.
  • the synthetic coumestrol may be utilized in animal raising in all of the ways disclosed in the aforementioned Bickofl and Booth application.
  • the coumestrol esters exhibit essentially the same estrogenic properties, qualitatively and quantitatively, as coumestrol.
  • the esters can also be employed in animal raising in all of the ways disclosed in the aforesaid Bickoif and Booth application, in place of coumestrol.
  • esters of coumestrol with aliphatic carboxylic acids such as acetic, propionic, butyric, isobutyric, valeric, caproic, caprylic, capric, lauric, myristic, palmitic, stearic, oleic, palmitoleic, arachidic, etc.
  • the estrogenic activity of coumestrol diacetate is illustrated by the following example:
  • estrogenic assays were conducted by feeding female mice with a basal ration containing coumestrol diacetate. A control batch of mice were fed the basal ration as such. After a period of 6 days, the mice were sacrificed and their uteri were excised and weighed. An increase in uterine weight denotes estrogenic activity in the material under test, the greater the uterine weight over h 90ntrol, the more potent the material tested.
  • the basal ration had the following composition:
  • mice were fed with the ration ad' libitum, supplying a definite amount of ration to each animal so that at the end of the test the amount of ration consumed [by each animal can be calculated whereby to determine the amount of test material ingested by each animal.
  • Coumestrol diacetate 1 42 It is well known in the field of animal husbandry that it is often desirable to'provide animals with estrogenic preparations particularly for the purpose of increasing weight gain and increasing efficiency of feed utilization. Such effects can be obtained by adding to the regular diet a minor proportion of diethyl stilbestrol. Also, estrogenic agents such as diethyl stilbestrol can be implanted subcutaneously in animals to obtain the desired effects. Such procedure is commonly employed with fowls. Coumestrol and its esters display estrogenic properties and can be employed in place of known estrogenic compounds, as in feeds or in subcutaneous implantation, to accomplish like results of accelerating weight gain and increasing the proportion of flesh produced per lb. of feed.
  • These compounds constitute a source of high and uniform estrogenic potency. As a consequence they can be administered to animals in controlled dosages to obtain predetermined physiological responses. Problems of low estrogenic concentration and variable estrogenic activity as encountered in direct feeding of forage containing natural estrogenic principles are completely obviated. Moreover, administration of coumestrol or its esters does not involve any physical difiiculty of feeding because the compounds can be administered in feeds or other compositions the ingredients of which can be selected to be compatible with the digestive systems or other characteristics of the animals in question. Also, the compounds can be administered by subcutaneous implantation or other techniques which require an active material free from extraneous components.
  • Coumestrol and its esters may be employed in animal husbandry in the same manner as convention with diethylstil bestrol and other known estrogenic agents.
  • the compounds may be administered by incorporating them in conventional feeds; by dispersion in water or other fluid; by addition to grit fed to birds; by administration in capsules, pellets or by injection; by implantation of pellets, and so forth.
  • the amount of the compound to be administered will of course vary depending on the type of animal, the body weight thereof, the physiological response desired, and the mode of administration.
  • dosage thereof may be that physiologically equivalent to about from 0.01 to 8 milligrams of diethylstilbestrol per lbs. of body weight per day.
  • the feed may consist mainly of vegetable material such as corn, wheat, barley, milo, hay, dehydrated alfalfa or other forage material, soybean meal, cottonseed meal,
  • distillers grains peanut meal, oat hulls, bran, corn stalks,
  • the feed may contain the usual supplements such as mineral salts, vitamin preparations, fish meal, fish oil, linseed oil, antibiotic supplements, and so forth.
  • the feed may contain on the order of 0.001 to 1 lb. of coumestrol or coumestrol ester per ton of feed.
  • the compounds may be applied for example to chickens, turkeys, geese, ducks, swine, sheep, cattle, horses, and so forth. Thereby, important practical effects are gained including increased rate of gain and increased efficiency of feed utilization.
  • the invention is of particularly practical value as applied to animals, such as steers, which are grown primarily for meat. coumestrol or its esters the animals are caused to gain weight more rapidly and produce more flesh per unit weight of feed with resulting economic benefits.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

2,884,427 SYNTHESIS OF COUMESTROL AND ITS ESTERS Oliver H. Emerson, Orinda, and Emanuel M. Bickofi,
Berkeley, Calif., assignors to the United States of America as represented by the Secretary of Agriculture No Drawing. Application January 22, 1958 Serial No. 710,586
1 4 Claims. (Cl. 260-3431) (Granted under Title 35, US. Code (1952), see. 266) A non-exclusive, irrevocable, royalty-free license in the invention herein described, throughout the world for all purposes of the United States Government, with the power to grant sub-licenses for such purposes, is hereby granted to the Government of the United States of America.
This invention relates in general to coumarin derivatives and processes for synthesizing them. The objects of the invention include the provision of novel methods for synthesizing coumestrol and its esters and the provision of new cournarin derivatives valuable as intermediates in the preparation of coumestrol and the esters thereof. Further objects and advantages of the invention will be evident from the following description.
In the copending patent application of E. M. Bickofif and A. N. Booth, Serial No. 693,785, filed Oct. 31, 1957, there is disclosed a previously unknown compound and methods for isolating it from forage crops such as ladino clover; The inventors also disclose that the compound exhibits estrogenic activity and may be employed in animal raising to obtain increased weight gain and increased efiiciency of steed utilization. The compound in question has been named coumestrol by the inventors and structu-rally it is 7',6dihydroxycoumarino (3',4'-3,2) coumarone having the formula:
The compound will be referred to herein as coumestrol EXAMPLE I a. Preparation of 3(2,4-dimethoxyphenyl)-4,7- dihydroxy coumarin Omega (2,4-dimethoxyphenyl) resacetophenone (3.1 g.), acetone (50 ml.), methyl chloroformate (2 ml.), and potassium carbonate (8 g.) were refluxed for four hours. The reaction mixture was cooled, diluted with 100 ml. of water and acidified with hydrochloric acid. The precipitate was filtered, washed with Water and dried. The dry precipitate was dissolved in about 20 ml. of methanol and to this solution was added sufi'icient of a 20% solution of potassium hydroxide in methanol to turn alizarinyellow orange (pH about 11). The solution was refluxed for minutes under an inert atmosphere, then cooled, diluted with water, and acidified with hydrochloric acid. The precipitate was filtered off and recrystallized [from alcohol. The product, 3(2,4-dimethoxyphenyl)-4,7-dihydroxy coumarin, obtained in a yield of 75%, had a melting point of 250-255 C. Analysis.--Caleulated for ice 2 C H O C, 64.95%; H, 4.49%. H, 4.5%
The reactions involved in this step are illustrated by the equations below:
Found: C, 65.0%;
HO on ornob-m oo-om-R' 0 0112060 OH i JOCH methanol- 15 l KOH yield of 60%.
The reaction in this step is illustrated by the equat1on-- (B O CH: CH3
O i OH 0. Preparation of coumestrol diacetate The coumestrol produced as above described was suspended in a mixture of 10 ml. of acetic anhydride and l g. of fused sodium acetate. The mixture was brought to a boil for a few minutes, then poured into water;
The coumetrol diacetate was filtered off and recrystallized from acetic acid. The recrystallized product had a melting point of 234-23S C. Analysis.Calculated for C H O C, 64.75%; H, 3.44%. Found: C, 64.7%; H, 3.51% 3 (2,4-dimethoxyph-enyl) -4,7-dihydroxy coumarin. product may also be termed 7',6-diacetyloxy coumarino. (3,4'-3,2) -coumarone. It has the formula- OHIg 0- The yield was 50%, based on the amount of The It will be found in a practice of the method exemplified above that many variations may be followed within the scope of the invention. For example, regarding the first step of the process (part a, above) a preferred starting material is omega (2,4-dimethoxyphenyl) resacetophenone. However, it is not essential that the substituents at the 2 and 4 positions he methoxy groups; other alkoxy substituents may be present at these positions, Thus in general the starting material may be an omega (2,4-dialkoxyphenyl) resacetophenone. Preferably, the 'alkoxy groups are of short carbon chain length such as methoxy, ethoxy, propoxy, isopropoxy, or butoxy. Such alkoxy groups are easily converted into hydroxy groups as. required in a further step of the synthesis. It is of course essential that the alkoxy groups be at the 2 and 4 positions so that the desired end product will be produced. The omega (2,4-dialkoxyphenyl) resacetophenones may be prepared as well known in the art by condensation of resorcinol with a 2,4-dialkoxyphenyl acetonitrile in the presence of HCl and zinc chloride.
Having selected a starting compound from the group of omega (2,4-dialkoxyphenyl) resacetophenones, this compound, as illustrated in Example I, part a, is reacted with at least two moles, but preferably an excess, of an alkyl haloformate. Methyl chloroformate is generally preferred as the latter reactant but analogous esters such as the ethyl, propyl, isopropyl, or butyl esters of chloroformic, bromoformic, or iodoforrnic acid may be employed. The reaction is conducted under essentially anhydrous conditions. The temperature of reaction is not critical and may vary, for example, from O to 100 C. Usually a temperature of about 50-70 C. is preferred as providing rapid rate of reaction without danger of decomposition. ,An inert solvent is preferably added to the reactants to promote contact therebetween. Suitable solvents are for example, benzene, toluene, xylene, dioxane, acetone, ether, methyl-ethyl ketone, diethyl ketone, diisopropyl ether, the dimethyl or diethyl ethers of ethylene glycol, etc. In general refluxing the reactants in acetone (boiling point 56 C.) is preferred. Also, to promote the reaction an esterification promoter having moderate alkalinity is preferably employed. For such purpose, one may employ an alkali metal carbonate or bicarbonate or a tertiary amine such as pyridine, quinoline, N-dimethyl aniline, N-dimethyl' cyclohexylamine, N-methyl piperidine, etc. The alkaline agent is added in at least the stoichiometrical amount required to neutralize the hydrogen halide evolv d in the reaction. As disclosed in the first equation following part a of Example I, the substituted resacetophenone and haloformate react to form an intermediate which may be described as a 2-hydroxy-4-alkylcarbonatophenyl-m-carbomethoxy-2,4-dimethoxybenzyl ketone. It is to be observed that the hydroxy group at the 2 position is not esterified because it is chelated with the carbonyl group attached at the l-position. Where the reaction is carried out in the presence of sodium carbonate or the like this intermediate is produced as a salt, or more accurately, a phenate, and in isolating it from the reaction mixture it is preferred to acidify the mixture to convert the intermediate to the free phenol form. For such purpose one may employ any acid as hydrochloric, sulphuric, acetic, phosphoric, .etc. product since the free phenol form is relatively insoluble in water.
In order to form the desired 3(2,4-dialkoxyphenyl)- 4,7-dihydroxy coumarin from the intermediate referred to immediately above, the intermediate is contacted with an alkaline agent such as potassium hydroxide, sodium hydroxide, an alkali metal alcoholate, or the like. The reaction may be conducted in an aqueous system but preferably the reactants are dissolved in an inert organic solvent such as methanol, ethanol, propanol, isopropanol, any of the isomeric butyl alcohols, the mono-methyl or mono-ethyl ethersof ethylene glycol, etc. The amount This step facilitates isolation-of the.
tion of gummy by-products it is preferred to conduct the reaction under an inert atmosphere, for example, under nitrogen. After the reaction is complete the salt of the 3(2,4-dialkoxyphenyl)-4,7-dihydroxy coumarin is treated with an acid such as hydrochloric, sulphuric, acetic, etc. to produce the free phenol form of this compound.
I This facilitates its isolation since the free phenol form para-chloro-aniline, and the like.
ture.
is relatively insoluble in water.
In the next step of the synthesis, illustrated in Example I, part b, the 3(2,4-dialkoxyphenyl)-4,7-dihydroxy coumarin is dealkylated and cyclized to form coumestroL, To accomplish this, the substituted coumarin is heated with a salt of an aromatic amine and a hydrohalic acid. Suitable salts are, for example, the hydrochlorides or hydrobromides of aniline, alpha-naphthyl amine, betanaphthyl amine, o-toluidine, m-toluidine, p-toluidine,
The amine salt is provided in an amount to furnish 2 mols thereof per mol of substituted coumarin. Preferably, an excess of amine salt is employed to operate both as reactant and as a flux to lower the melting point of the reaction mixture. The reaction essentially involves mixing the substituted coumarin and amine salt and heating at a temperature at which the mixture becomes liquid. This temperature will usually be about ZOO-300 C. depending on the amine salt used and the proportion thereof in the mix- The reaction is preferably conducted under an atmosphere of an inert gas, such as carbon dioxide or nitrogen, to minimize oxidative side-reactions. Com pletion of the reaction is indicated by the crystallization of coumestrol from the molten mass whereby the mass eventually becomes essentially solid. Coumestrol may be recovered from the reaction mixture by first extracting the amine salt therefrom with water and re-crystal lizing the residual coumestrol from methanol or methamol-chloroform. Coumestrol may also be isolated by distillation since it sublimes at 325 C. under atmospheric pressure or at 175 C. under vacuum (7 microns pressure).
In our researches we have found that 3(2,4-dimethoxyphenyl)-4,7-dihydroxy coumarin may be converted to coumestrol by refluxing with concentrated aqueous hydriodic acid. This procedure is, however, not satisfactory as the yield of coumestrol is low-about 20%-' whereas by the described process involving heating of the coumarin derivative with an amine salt, the yield of coumestrol is is evident that were the starting material to contain alkoxy groups other than methoxy groups the same result would follow. For example, if the amine salt were reacted with 3(2,4 diisopropoxyphenyl) 4,7-dihydroxy coumarin, the reaction would involve conversion of the isopropoxy groups to hydroxy groups and cyclization to produce coumestrol. In the same way coumestrol would. be produced regardless of the identity of the alkoxy groups on the original starting compound or the intermediate compounds and these alkoxy groups could be for example methoxy, ethoxy, propoxy, isopropoxy or butoxy with the same end result. To further illustrate this point, assume that the original starting material selected would be omega (2,4-diethoxyphenyl) resactophenone. In such case amine salt would produce coumestrol.
Referring now to part c of Example I, usually it is preferred to esterify the coumestrol since the esters are more stable and more easily crystallized than the coumestrol itself. To this end the coumestrol prepared by the cyclization and dealkylation described above is reacted with an acylating agent, for example, the anhydride, chloride, bromide or iodide of an acid such as acetic, propionic, lbutyric, isobutyric, valeric, caproic, caprylic, capric, lauric, palmitic, stearic, oleic, palmitoleic, arachidic, etc. The acylating agent is employed in a proportion to furnish at least 'moles of the acylating agent per mole of coumestrol thus to ensure esten'fying both hydroxyl groups. To enhance Contact between the reactants an inert solvent may be added, or, in the alternative, such as excess of acylating agentmay be used as to function as both reactant and solvent. Suitable inert solvents are for example benzene, toluene, xylene, dioxane, acetone, ether, methyl-ethyl ketone, diethyl ketone, diisopropyl ether, the diethyl ether of ethylene glycol, etc. The temperature of reaction is not critical andmayvbe-variedfrom about 0 to .150 C. To expedite "the e'sterification; a conventional esterificationpromoter is added, for example, the alkali metal salt of the acid in question (e.g., sodium acetate where coumestrol acetate is being prepared), pyridine, quinoline, potassium carbonate," and the like. The coumestrol esters are readily isolatable from the reaction mixture on addition of water since they are relatively insoluble in this solvent.
The intermediate compounds, which may be produced in accordance with the procedure illustrated in Example I, part a, are new compounds not heretofore prepared or described. These 3(2,4-dialkoxyphenyl)-4,7-dihydroxy coumarins may be depicted by the formulao-Qoa C// (in R wherein the ORs represent the same, or dissimilar, alkoxy radicals particularly lower alkoxy radicals such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, etc. These compounds are particularly useful as intermediates in the preparation of coumestrol and coumestrol esters as described herein.
The coumestrol as produced in accordance with the invention is identical with coumestrol as isolated from plant materials and can be employed in the same manner as native coumestrol for its estrogenic activity. Thus the synthetic coumestrol may be utilized in animal raising in all of the ways disclosed in the aforementioned Bickofl and Booth application. Moreover, the coumestrol esters exhibit essentially the same estrogenic properties, qualitatively and quantitatively, as coumestrol. Thus the esters can also be employed in animal raising in all of the ways disclosed in the aforesaid Bickoif and Booth application, in place of coumestrol. For such purposes one may use the esters of coumestrol with aliphatic carboxylic acids such as acetic, propionic, butyric, isobutyric, valeric, caproic, caprylic, capric, lauric, myristic, palmitic, stearic, oleic, palmitoleic, arachidic, etc.
The estrogenic activity of coumestrol diacetate is illustrated by the following example:
EXAMPLE II Estrogenic assays were conducted by feeding female mice with a basal ration containing coumestrol diacetate. A control batch of mice were fed the basal ration as such. After a period of 6 days, the mice were sacrificed and their uteri were excised and weighed. An increase in uterine weight denotes estrogenic activity in the material under test, the greater the uterine weight over h 90ntrol, the more potent the material tested. The basal ration had the following composition:
In these tests, the mice were fed with the ration ad' libitum, supplying a definite amount of ration to each animal so that at the end of the test the amount of ration consumed [by each animal can be calculated whereby to determine the amount of test material ingested by each animal.
The results of the assays are set forth below:
Amount Uterine Material tested fed, mg. weight,
per mouse mg.
Control (basal ration) 17 Coumestrol diacetate 1 42 It is well known in the field of animal husbandry that it is often desirable to'provide animals with estrogenic preparations particularly for the purpose of increasing weight gain and increasing efficiency of feed utilization. Such effects can be obtained by adding to the regular diet a minor proportion of diethyl stilbestrol. Also, estrogenic agents such as diethyl stilbestrol can be implanted subcutaneously in animals to obtain the desired effects. Such procedure is commonly employed with fowls. Coumestrol and its esters display estrogenic properties and can be employed in place of known estrogenic compounds, as in feeds or in subcutaneous implantation, to accomplish like results of accelerating weight gain and increasing the proportion of flesh produced per lb. of feed. These compounds constitute a source of high and uniform estrogenic potency. As a consequence they can be administered to animals in controlled dosages to obtain predetermined physiological responses. Problems of low estrogenic concentration and variable estrogenic activity as encountered in direct feeding of forage containing natural estrogenic principles are completely obviated. Moreover, administration of coumestrol or its esters does not involve any physical difiiculty of feeding because the compounds can be administered in feeds or other compositions the ingredients of which can be selected to be compatible with the digestive systems or other characteristics of the animals in question. Also, the compounds can be administered by subcutaneous implantation or other techniques which require an active material free from extraneous components. Another point is that the compounds are free from growth-inhibiting factors, saponins, or other detrimental agents naturally present in forage materials. Consequently, their administration to animals yields the useful results of attaining desired physiological response without any undesired side effects such as growth inhibition, bloating, etc.
Coumestrol and its esters may be employed in animal husbandry in the same manner as convention with diethylstil bestrol and other known estrogenic agents. Thus the compounds may be administered by incorporating them in conventional feeds; by dispersion in water or other fluid; by addition to grit fed to birds; by administration in capsules, pellets or by injection; by implantation of pellets, and so forth. The amount of the compound to be administered will of course vary depending on the type of animal, the body weight thereof, the physiological response desired, and the mode of administration. For example where the estrogenic compound is administered in admixture with a feed, dosage thereof may be that physiologically equivalent to about from 0.01 to 8 milligrams of diethylstilbestrol per lbs. of body weight per day. Generally it is preferred to administer the com pounds by incorporating them in a conventional feed. Thus the feed may consist mainly of vegetable material such as corn, wheat, barley, milo, hay, dehydrated alfalfa or other forage material, soybean meal, cottonseed meal,
distillers grains, peanut meal, oat hulls, bran, corn stalks,
For a highcorn cobs, sorghum, beet pulp, or the like. energy diet a major proportion of grain or oil-seed. meal is preferred. In addition to themain vegetable portion, the feed may contain the usual supplements such as mineral salts, vitamin preparations, fish meal, fish oil, linseed oil, antibiotic supplements, and so forth. In general the feed may contain on the order of 0.001 to 1 lb. of coumestrol or coumestrol ester per ton of feed. The compounds may be applied for example to chickens, turkeys, geese, ducks, swine, sheep, cattle, horses, and so forth. Thereby, important practical effects are gained including increased rate of gain and increased efficiency of feed utilization.
As noted above, the invention is of particularly practical value as applied to animals, such as steers, which are grown primarily for meat. coumestrol or its esters the animals are caused to gain weight more rapidly and produce more flesh per unit weight of feed with resulting economic benefits.
Having thus described our invention, we claim:
1. The method for preparing 7',6-dihydroxycoumarino- Thus by administration of (3',4'-3, 2) coumarone which comprises heating, at about from 200 to 300 C., 3(2,4-diloweralkoxyphenyl)-4,7-di hydroxy coumarinwith a salt selected from the group consisting ofthe hydrochlorides and hydrobromides of aniline, alpha-naphthyl amine, beta-naphthyl amine, o-toluidinc,
.m-toluidine, p-toluidine, and para-chloro aniline to produce 7,6-dihydroxycoumarino-(3',4'-3,2) coumarone. 2. The method of claim 1 wherein the salt is aniline hydrochloride.
3. Themethod for preparing 7,6-
duce 7',6-dihydroxycoumarino .(3',4'3.,2) coumarone.
4. The method of claim 3 wherein the salt is hydrochloride.
References Cited in the file of this patent Shriner et al.: Iden. of Org. Cmpds p. 104, Wiley- (1948).
Boyd .et al.:J. Chem. -Soc., pp. 174-176 (1948). Mentzer: Chem. Abst, vol. 45, p. 10245C (1951).
hydroxycoumarino- (3',4-3,2) coumarone which comprises heating, at about

Claims (1)

1. THE METHOD FOR PREPARTING 7''6-DIHYDROXYCOUMARINO(3'',4''-3,2) COUMARONE WHICH COMPRISES HEATING, AT ABOUT FROM 200 TO 300* C., 3(2,4-DILOWERAALKOXYPHENYL)-4,7-DIHYDROXY COUMARIN WITH A SALT SELECTED FROM THE GROUP CONSISTING OF THE HYDROCHLORIDES AND HYDROBROMIDES OF ANILINE, ALPHA-NAPHTHYL AMINE, BETA-NAPHTHYL AMINE O-TOLUIDINE, M-TOLUIDINE, P-TOLUIDINE, AND PARA-CHLORO ANILINE TO PRODUCE 7''6-DIHYDROXYCOUMARINO-(3'',4''-3,2) COUMARONE.
US710586A 1958-01-22 1958-01-22 Synthesis of coumestrol and its esters Expired - Lifetime US2884427A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US710586A US2884427A (en) 1958-01-22 1958-01-22 Synthesis of coumestrol and its esters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US710586A US2884427A (en) 1958-01-22 1958-01-22 Synthesis of coumestrol and its esters

Publications (1)

Publication Number Publication Date
US2884427A true US2884427A (en) 1959-04-28

Family

ID=24854648

Family Applications (1)

Application Number Title Priority Date Filing Date
US710586A Expired - Lifetime US2884427A (en) 1958-01-22 1958-01-22 Synthesis of coumestrol and its esters

Country Status (1)

Country Link
US (1) US2884427A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393729A (en) * 1992-09-10 1995-02-28 Bayer Aktiengesellschaft 3-aryl-pyrone derivatives
EP0761669A2 (en) * 1995-09-08 1997-03-12 Eli Lilly And Company Pentacyclic compounds, intermediates, processes, compositions, and methods
CN107540678A (en) * 2016-06-24 2018-01-05 中国科学院上海药物研究所 A kind of intramolecular intersects dehydrogenation coupling and prepares the cumarin simultaneously method of heteroaryl cyclics and its derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393729A (en) * 1992-09-10 1995-02-28 Bayer Aktiengesellschaft 3-aryl-pyrone derivatives
EP0761669A2 (en) * 1995-09-08 1997-03-12 Eli Lilly And Company Pentacyclic compounds, intermediates, processes, compositions, and methods
EP0761669A3 (en) * 1995-09-08 1997-10-29 Lilly Co Eli Pentacyclic compounds, intermediates, processes, compositions, and methods
CN107540678A (en) * 2016-06-24 2018-01-05 中国科学院上海药物研究所 A kind of intramolecular intersects dehydrogenation coupling and prepares the cumarin simultaneously method of heteroaryl cyclics and its derivative
CN107540678B (en) * 2016-06-24 2021-12-07 中国科学院上海药物研究所 Method for preparing coumarin heteroaromatic ring compound and derivative thereof through intramolecular cross dehydrogenation coupling

Similar Documents

Publication Publication Date Title
US4163746A (en) Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same
US3373024A (en) Estrogenic compounds and animal growth promoters
US4287201A (en) Anovulatory method and chicken feed compositions
US2884427A (en) Synthesis of coumestrol and its esters
US3926992A (en) Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
US4221791A (en) Substituted quinoxaline dioxides
US4303657A (en) Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof
US4100284A (en) 1,4-Dioxo- and 4-oxoquinoxaline-2-carboxaldehyde sulfonylhydrazones and certain derivatives thereof
US4239772A (en) Allyl and propyl zearalenone derivatives and their use as growth promoting agents
US2929713A (en) Preparation of coumestrol esters and use thereof
US3239348A (en) Estrogenic compounds and animal growth promoters
US3373037A (en) Estrogenic compounds and animal growth promoters
US2987398A (en) Coumestrol ethers and use thereof
HU202841B (en) Process for producing compositions for enhancing productivity of animals containing pyridyl-ethanol-amine as active component and process for producing the active components
US3839363A (en) Synthesis of zearalanone and related compounds and intermediates useful in the synthesis thereof
US3948911A (en) Substituted quinoxaline-2-carboxamide 1,4-dioxides
IL23314A (en) Esters of the antibiotic pleuro-mutilin,their production and animal feed supplement containing same
CA1235940A (en) Mixtures which promote growth and increase production, and feeds and drinking liquids which contain small amounts of these mixtures
US4241061A (en) Oxazolidinyl-quinoxalines and use as growth promoters
US3763162A (en) Transesterification of quinoxaline-2-carboxylic acid esters
US2895964A (en) Purification of coumestrol
US2927027A (en) Feed efficiency promoting composition
US3925423A (en) Resorcyclic acid lactones and their production
US3373032A (en) Estrogenic compounds and animal growth promoters
EP0104836B1 (en) Feed compositions containing a (1-oxo-2-pyridyl) disulfide